| Literature DB >> 34066235 |
Min Jae Yang1, Jin Hong Kim1, Jae Chul Hwang1, Byung Moo Yoo1, Yu Ji Li1, Soon Sun Kim1, Sun Gyo Lim1.
Abstract
Endoscopic retrograde cholangiopancreatography (ERCP) in patients who have undergone a Billroth II gastrectomy is a major challenge. This study aimed to evaluate the outcomes of the road-map technique for duodenal intubation using a side-viewing duodenoscope for ERCP in Billroth II gastrectomy patients with naïve papilla, and to analyze the formation and release patterns of common bowel loops that occur when the duodenoscope navigates the afferent limb. The duodenoscopy approach success rate was 85.8% (97/113). In successful duodenoscopy approach patients, there were five bowel looping patterns that occurred when the preceding catheter-connected duodenoscope was advanced into the duodenum: (1) reverse ɣ-loop (29.9%), (2) fixed reverse ɣ-loop (5.2%), (3) simple U-loop (22.7%), (4) N-loop (28.9%), and (5) reverse alpha loop (13.4%). The duodenoscopy cannulation and duodenoscopy therapeutic success rates were 81.4% (92/113) and 80.5% (91/113), respectively, while the overall cannulation and therapeutic success rates were 92.0% (104/113) and 87.6% (99/113), respectively. Bowel perforation occurred in three patients (2.7%). The road-map technique may benefit duodenoscope-based ERCP in Billroth II gastrectomy patients by minimizing the tangential axis alignment between the duodenoscopic tip and driving of the afferent limb, and by predicting and counteracting bowel loops that occur when the duodenoscope navigates the afferent limb.Entities:
Keywords: catheters; cholangiopancreatography endoscopic retrograde; duodenoscopy; gastrectomy; pneumoperitoneum
Year: 2021 PMID: 34066235 PMCID: PMC8150314 DOI: 10.3390/jpm11050404
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Figure 1A flow diagram for study cohort. P-E RV, percutaneous-endoscopic rendezvous; PTCS, percutaneous transhepatic cholangioscopy; PASR, percutaneous antegrade stone removal; PABS, percutaneous antegrade biliary stenting.
Figure 2The loop patterns of inserting a duodenoscope in the afferent loop. (a) Reverse gamma (ɣ) loop, (b) fixed reverse gamma loop.
Figure 3The loop patterns of inserting a duodenoscope in the afferent loop. (a) Simple U-loop, (b) N-loop, (c) reverse alpha (α) loop.
Baseline characteristics of the patients (N = 113).
| Age, mean ± SD | 70.9 ± 9.4 |
| Sex, n (%) | 84 (74.3)/29 (25.7) |
| Reconstruction type, n (%) | |
| Billroth II/Billroth II with Braun anastomosis | 84 (74.3)/29 (25.7) |
| Antecolic/retrocolic | 83 (73.5)/30 (26.5) |
| Billroth II gastrectomy indication, n (%) | |
| Gastric cancer/peptic ulcer | 78 (69.0))/35 (31.0) |
| Duration from Billroth II gastrectomy, n (%) | |
| ≤5 year/>5 years | 25 (22.1)/88 (77.9) |
| Reasons for ERCP, n (%) | |
| Common bile duct stone suspicion | 83 (73.5) |
| Indeterminate biliary stricture | 6 (5.3) |
| Malignant biliary stricture | 21 (18.6) |
| Recurred gastric cancer | 6 |
| Cholangiocarcinoma (hilar/distal) | 8 (2/6) |
| Pancreatic cancer | 4 |
| Ampullary cancer | 2 |
| Gallbladder cancer | 1 |
| Bile leakage | 1 (0.9) |
| Pancreatic duct leakage/chronic pancreatitis | 2 (1.8) |
| Periampullary diverticulum, n (%) | 33 (29.7) |
| Preprocedural laboratory finding, mean ± SD | |
| White blood cell,/µL | 8076 ± 4155 |
| Hemoglobin, g/dL | 11.8 ± 1.6 |
| Total bilirubin, mg/dL | 3.2 ± 4.2 |
SD, standard deviation; ERCP, endoscopic retrograde cholangiopancreatography.
Endoscopic retrograde cholangiopancreatography outcomes in Billroth II gastrectomy patients (N = 113).
| Used catheter, n (%) | |
| Rotatable sphincterotome/triple-lumen balloon catheter | 73 (64.6)/40 (35.4) |
| Duodenoscopy/overall approach success, n (%) | 97 (85.8)/109 (96.5) |
| Causes of duodenoscopy approach failure, n | 16 |
| Bowel perforation occurrence | 2 |
| Long U-loop formation before reaching the ligament of Treitz | 10 |
| Failure in passing the ligament of Treitz | 4 |
| Duodenoscopy/overall cannulation success, n (%) | 92 (81.4)/104 (92.0) |
| Duodenoscopy/overall therapeutic success, n (%) | 91 (80.5)/99 (87.6) |
| Reasons for overall therapeutic failure, n | 14 |
| Approach failure albeit forward scope or P-E RV | 1 |
| Cannulation failure/occurrence of bowel perforation | 6/3 |
| Failure in complete stone extraction | 3 |
| Failure in biliary stenting due to tight stricture | 1 |
| Rescue methods for overall therapeutic failure, n (%) | |
| PTCS/percutaneous antegrade stone removal | 5/3 |
| Percutaneous antegrade stenting/palliative hepaticojejunostomy | 1/1 |
| Conservative treatment | 1 |
| Surgery following bowel perforation | 3 |
| Primary repair and cholecystectomy | 1 |
| Primary repair and cholecystectomy and choledochotomy | 2 |
| Overall adverse events, n (%) | 8 (7.1) |
| Duodenoscope-related perforation | 3(2.7) |
| Pancreatitis | 3 (2.7) |
| Cholecystitis | 1 (0.9) |
| Transient respiratory failure | 1 (0.9) |
P-E RV, percutaneous-endoscopic rendezvous; PTCS, percutaneous transhepatic cholangioscopy.
Loop patterns analysis of inserting a duodenoscope in the afferent loop in patients with duodenoscopy approach success (N = 97).
| Reverse ɣ-loop * | 29 (29.9%) |
| Fixed reverse ɣ-loop | 5 (5.2%) |
| Simple U-loop | 22 (22.7%) |
| N-loop * | 28 (28.9%) |
| Reverse α-loop * | 13 (13.4%) |
* Three loop patterns could be converted into each other if the intraabdominal adhesion was not severe and the afferent limb was not firmly fixed by the ligament of Treitz.